(Total Views: 446)
Posted On: 03/07/2021 3:44:51 PM
Post# of 154003
Exactly - seems like first half of last year most of the EIND success stories were very critical patients. Maybe they were not on dex because the RECOVERY trial was not out yet. Regardless, you saw the bloodwork results for Dr. S patients at Montefiori. You know it works in critical.
Great data from CD 10 but too many mild patients.
And you still only end up with 62 critical patients? And you do not control for age in the placebo group.? And you do not take recommendations of DSMC? Then you miss every endpoint.
Silver lining this may create buying opportunities in the next few weeks. You know it works in critical. Can they enroll critical fast.?
Great data from CD 10 but too many mild patients.
And you still only end up with 62 critical patients? And you do not control for age in the placebo group.? And you do not take recommendations of DSMC? Then you miss every endpoint.
Silver lining this may create buying opportunities in the next few weeks. You know it works in critical. Can they enroll critical fast.?
(2)
(0)
